Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfred Hauben

Showing results (31-40 of 112) with videos related to

Pageof 12
Sort By:
British Journal of Clinical Pharmacology|November 4, 2004
Drug-induced pancreatitis: lessons in data miningManfred Hauben, Lester Reich
CNS Drugs|April 8, 2006
Reports of acute angle closure glaucoma-related adverse events with SSRIs: results of a disproportionality analysisManfred Hauben, Lester Reich
Drug Safety|February 13, 2003
Quantitative methods in pharmacovigilance: focus on signal detectionManfred Hauben, Xiaofeng Zhou
Expert Review of Clinical Pharmacology|April 29, 2015
Bevacizumab-associated diverticulitis: results of disproportionality analysisManfred Hauben, Eric Hung
Journal of Clinical Pharmacology|March 22, 2005
Potential utility of data-mining algorithms for early detection of potentially fatal/disabling adverse drug reactions: a retrospective evaluationManfred Hauben, Lester Reich
Clinical Therapeutics|May 15, 2026
Verbal Expressions of Probability in Pharmacovigilance: Most Likely Too AmbiguousManfred Hauben, Nayanika Rivankar
Clinical Therapeutics|January 29, 2021
Effects of the COVID-19 Pandemic on Spontaneous Reporting: Global and National Time-series AnalysesManfred Hauben, Eric Hung
The Annals of Pharmacotherapy|November 13, 2004
Data mining, drug safety, and molecular pharmacology: potential for collaborationManfred Hauben, Lester Reich
Movement Disorders : Official Journal of the Movement Disorder Society|January 11, 2005
Valproate-induced parkinsonism: use of a newer pharmacovigilance tool to investigate the reporting of an unanticipated adverse event with an "old" drugManfred Hauben, Lester Reich
Platelets|November 28, 2006
Rosiglitazone-induced immune thrombocytopeniaManfred Hauben, Muhammad Younus
Pageof 12

Showing results (31-40 of 112) with videos related to

Sort By:
Pageof 12
British Journal of Clinical Pharmacology|November 4, 2004
Drug-induced pancreatitis: lessons in data miningManfred Hauben, Lester Reich
CNS Drugs|April 8, 2006
Reports of acute angle closure glaucoma-related adverse events with SSRIs: results of a disproportionality analysisManfred Hauben, Lester Reich
Drug Safety|February 13, 2003
Quantitative methods in pharmacovigilance: focus on signal detectionManfred Hauben, Xiaofeng Zhou
Expert Review of Clinical Pharmacology|April 29, 2015
Bevacizumab-associated diverticulitis: results of disproportionality analysisManfred Hauben, Eric Hung
Journal of Clinical Pharmacology|March 22, 2005
Potential utility of data-mining algorithms for early detection of potentially fatal/disabling adverse drug reactions: a retrospective evaluationManfred Hauben, Lester Reich
Clinical Therapeutics|May 15, 2026
Verbal Expressions of Probability in Pharmacovigilance: Most Likely Too AmbiguousManfred Hauben, Nayanika Rivankar
Clinical Therapeutics|January 29, 2021
Effects of the COVID-19 Pandemic on Spontaneous Reporting: Global and National Time-series AnalysesManfred Hauben, Eric Hung
The Annals of Pharmacotherapy|November 13, 2004
Data mining, drug safety, and molecular pharmacology: potential for collaborationManfred Hauben, Lester Reich
Movement Disorders : Official Journal of the Movement Disorder Society|January 11, 2005
Valproate-induced parkinsonism: use of a newer pharmacovigilance tool to investigate the reporting of an unanticipated adverse event with an "old" drugManfred Hauben, Lester Reich
Platelets|November 28, 2006
Rosiglitazone-induced immune thrombocytopeniaManfred Hauben, Muhammad Younus
Pageof 12